Details of the Drug Formulations

General Information of Drug (ID: DM1KS78)

Drug Name
Talazoparib Drug Info
Synonyms Talazoparib (BMN 673); UNII-9QHX048FRV; 9QHX048FRV; Talazoparib [USAN:INN]; Talzenna; 4pjt; 2YQ
Indication
Disease Entry ICD 11 Status REF
Breast cancer 2C60-2C65 Approved [1]
Psoriatic arthritis FA21 Phase 3 [2]
Cross-matching ID
PubChem CID
135565082
CAS Number
1207456-01-6
TTD ID
D0GV8J
ACDINA ID
D01457

Full List of Drug Formulations Containing This Drug

Talazoparib 0.25 mg capsule
Company Formulation ID FDA Description
Pfizer Laboratories Div Pfizer F24298 Silicified Microcrystalline Cellulose (Smcc); Hpmc; Yellow Iron Oxide; Red Iron Oxide; Titanium Dioxide; Shellac; Black Iron Oxide; Potassium Hydroxide; Ammonium Hydroxide; Propylene Glycol
------------------------------------------------------------------------------------
Talazoparib 1 mg capsule
Company Formulation ID FDA Description
Pfizer Laboratories Div Pfizer F24302 Silicified Microcrystalline Cellulose (Smcc); Hpmc; Yellow Iron Oxide; Red Iron Oxide; Titanium Dioxide; Shellac; Black Iron Oxide; Potassium Hydroxide; Ammonium Hydroxide; Propylene Glycol
------------------------------------------------------------------------------------

References

1 2018 FDA drug approvals.Nat Rev Drug Discov. 2019 Feb;18(2):85-89.
2 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8313).